999
Views
46
CrossRef citations to date
0
Altmetric
Original Articles

Club Drugs: Reasons for and Consequences of Use

&
Pages 295-302 | Published online: 07 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Brian E. McCabe, Candace D. McConaha & Ashley L. Falcon. (2023) Social norms and club drug use of young adult college students during Music Week. Journal of Addictive Diseases 41:2, pages 149-155.
Read now
Ana Rita Silva & Ricardo Jorge Dinis-Oliveira. (2020) Pharmacokinetics and pharmacodynamics of dextromethorphan: clinical and forensic aspects. Drug Metabolism Reviews 52:2, pages 258-282.
Read now
Ansgar Rougemont-Bücking, Henrik Jungaberle, Milan Scheidegger, Marco C.G. Merlo, Veronique S. Grazioli, Jean-Bernard Daeppen, Gerhard Gmel & Joseph Studer. (2019) Comparing Mental Health across Distinct Groups of Users of Psychedelics, MDMA, Psychostimulants, and Cannabis. Journal of Psychoactive Drugs 51:3, pages 236-246.
Read now
Yanhui Liao, Yi-lang Tang & Wei Hao. (2017) Ketamine and international regulations. The American Journal of Drug and Alcohol Abuse 43:5, pages 495-504.
Read now
Joseph J. Palamar & Dimitra Kamboukos. (2014) An Examination of Sociodemographic Correlates of Ecstasy Use Among High School Seniors in the United States. Substance Use & Misuse 49:13, pages 1774-1783.
Read now
David M. Wood, Stewart Who, Graham Alldus, Denise Huggett, Michelle Nicolaou, Kerry Chapman, Mark Oakley, Eren Bessim, Kelvin Julian, Karen Sturgeon, John D. Ramsey & Paul I. Dargan. (2010) The development of the recreational drug outreach educational concept ‘Drug Idle’. Journal of Substance Use 15:4, pages 237-245.
Read now
BrentT. Mausbach, ShirleyJ. Semple, SteffanieA. Strathdee & ThomasL. Patterson. (2009) Predictors of safer sex intentions and protected sex among heterosexual HIV-negative methamphetamine users: an expanded model of the Theory of Planned Behavior. AIDS Care 21:1, pages 17-24.
Read now
Marcia L. Verduin, Marcia L. Verduin, Rebecca A. Payne, Aimee L. McRae, Sudie E. Back, Stacey A. Simpson, Rajesh Y. Sarang & Kathleen T. Brady. (2007) Assessment of Club Drug Use in a Treatment-Seeking Sample of Individuals with Marijuana Dependence. American Journal on Addictions 16:6, pages 484-487.
Read now
Lydia N. Drumright, Thomas L. Patterson & Steffanie A. Strathdee. (2006) Club Drugs as Causal Risk Factors for HIV Acquisition Among Men Who Have Sex with Men: A Review. Substance Use & Misuse 41:10-12, pages 1551-1601.
Read now

Articles from other publishers (36)

Maximilian Fascher, Sandra Nowaczynski, Carolin Spindler, Tilo Strobach & Markus Muehlhan. (2023) Neural underpinnings of response inhibition in substance use disorders: weak meta-analytic evidence for a widely used construct. Psychopharmacology.
Crossref
Alicja Lojszczyk, Rhonda Wilson, Jessica Wood & Alison Hutton. (2023) Motivational characteristics of recreational drug use among emerging adults in social settings: an integrative literature review. Frontiers in Public Health 11.
Crossref
Han Pham, Jessica Sieg, Sarah L. Seeley & Manoranjan S D’Souza. (2022) Differential methamphetamine-induced behavioral effects in male and female mice lacking regulator of G Protein signaling 4. Behavioural Brain Research 423, pages 113770.
Crossref
Alain Origer. 2022. Wohlbefinden und Gesundheit im Jugendalter. Wohlbefinden und Gesundheit im Jugendalter 343 361 .
Cassandra R. Doyno & C. Michael White. (2021) Sedative‐Hypnotic Agents That Impact Gamma‐Aminobutyric Acid Receptors: Focus on Flunitrazepam, Gamma‐Hydroxybutyric Acid, Phenibut, and Selank. The Journal of Clinical Pharmacology 61:S2.
Crossref
Martina Fregonese, Andrea Albino, Claudia Covino, Alessio Gili, Mauro Bacci, Alessia Nicoletti & Cristiana Gambelunghe. (2021) Drug Checking as Strategy for Harm Reduction in Recreational Contests: Evaluation of Two Different Drug Analysis Methodologies. Frontiers in Psychiatry 12.
Crossref
Olivia Engmann. 2021. Circadian Clock in Brain Health and Disease. Circadian Clock in Brain Health and Disease 129 152 .
Xiushi YangGuomei Xia. (2019) Causes and Consequences of Drug Abuse: A Comparison Between Synthetic Drug and Heroin Users in Urban China. AIDS Education and Prevention 31:1, pages 1-16.
Crossref
Roberta Biolcati & Giacomo Mancini. (2018) Club Drugs and Rave Parties: A Pilot Study on Synthetic Drug Consumption Styles in a Sample of Young Italian Ravers. The Open Public Health Journal 11:1, pages 474-484.
Crossref
Oliver G. Bosch & Erich Seifritz. (2016) The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans. Brain Research Bulletin 126, pages 47-60.
Crossref
Yansheng Yan, Shouli Wu, Liang Chen, Pingping Yan, Yuefeng Qiu, Meirong Xie, Zhenghua Wang & Xun Lin. (2016) Shift in HIV/AIDS Epidemic in Southeastern China: A Longitudinal Study from 1987 to 2015. International Journal of Environmental Research and Public Health 13:8, pages 794.
Crossref
Chaoxuan Dong. 2015. Ketamine. Ketamine 65 102 .
M. L. Zuccoli, A. Muscella, C. Fucile, R. Carrozzino, F. Mattioli, A. Martelli & S. Orengo. (2014) Paliperidone for the Treatment of Ketamine-Induced Psychosis: A Case Report. The International Journal of Psychiatry in Medicine 48:2, pages 103-108.
Crossref
Mylène Magrinelli Orsi, Serge Brochu, Denis Lafortune & Catherine Patenaude. (2014) Factors associated with the motivation to use psychoactive substances and the motivation to change in adolescents in an authoritarian context. Children and Youth Services Review 39, pages 11-19.
Crossref
Yingying Ding, Na He & Roger Detels. (2013) Circumstances of initiation into new-type drug use among adults in Shanghai: Are there differences by types of first new-type drug used?. Drug and Alcohol Dependence 131:3, pages 278-283.
Crossref
Chaoxuan Dong & K.J.S. Anand. (2013) Developmental neurotoxicity of ketamine in pediatric clinical use. Toxicology Letters 220:1, pages 53-60.
Crossref
Kevin Woodward & Kevin WoodwardK. N. Woodward. 2012. Toxicological Effects of Veterinary Medicinal Products in Humans. Toxicological Effects of Veterinary Medicinal Products in Humans 117 149 .
Rowan P. Ogeil, David J. Kennaway, Mark D. Salkeld, Shantha M. W. Rajaratnam & Jillian H. Broadbear. (2011) MDMA induces Per1, Per2 and c-fos gene expression in rat suprachiasmatic nuclei. Psychopharmacology 220:4, pages 835-843.
Crossref
Rowan P OGEIL, Shantha MW RAJARATNAM & Jillian H BROADBEAR. (2012) Ecstasy and sleep disturbance: Progress towards elucidating a role for the circadian system. Sleep and Biological Rhythms 10:1, pages 3-13.
Crossref
Flavio Pechansky, Lysa Remy, Hilary L. Surratt, Steven P. Kurtz, Thiago Botter Maio Rocha, Lisia Von Diemen, Daniela Benzano Bumaguin & James Inciardi. (2011) Age of Sexual Initiation, Psychiatric Symptoms, and Sexual Risk Behavior among Ecstasy and LSD Users in Porto Alegre, Brazil: A Preliminary Analysis. Journal of Drug Issues 41:2, pages 217-231.
Crossref
Rowan P. Ogeil, Shantha M.W. Rajaratnam, Jennifer R. Redman & Jillian H. Broadbear. (2010) Acute MDMA administration alters the distribution and circadian rhythm of wheel running activity in the rat. Brain Research 1359, pages 128-136.
Crossref
David W. Pantalone, David S. Bimbi, Catherine A. Holder, Sarit A. Golub & Jeffrey T. Parsons. (2010) Consistency and Change in Club Drug Use by Sexual Minority Men in New York City, 2002 to 2007. American Journal of Public Health 100:10, pages 1892-1895.
Crossref
Greg Phelps, H. Anton Speaker & Karen E. Sabol. (2010) Relationship between methamphetamine-induced behavioral activation and hyperthermia. Brain Research 1357, pages 41-52.
Crossref
REBECCA MCKETIN, KARINA HICKEY, KRISTINA DEVLIN & KERRI LAWRENCE. (2010) The risk of psychotic symptoms associated with recreational methamphetamine use. Drug and Alcohol Review 29:4, pages 358-363.
Crossref
Simona Pichini, Magi Farré, Sergio Abanades, Roberta Pacifici, Piergiorgio Zuccaro, Klaus Langohr & Rafael De La Torre. (2010) CLINICAL STUDY: FULL ARTICLE: Immunomodulating properties of gamma‐hydroxybutyrate (GHB), flunitrazepam and ethanol in ‘club drugs’ users. Addiction Biology 15:3, pages 336-345.
Crossref
RAFAEL DE LA TORRE. (2009) Commentary on Morgan et al. (2010): Ketamine abuse: first medical evidence of harms we should confront . Addiction 105:1, pages 134-135.
Crossref
Yvonne M. Terry-McElrath, Patrick M. O'Malley & Lloyd D. Johnston. (2009) Reasons for Drug Use among American Youth by Consumption Level, Gender, and Race/Ethnicity: 1976–2005. Journal of Drug Issues 39:3, pages 677-713.
Crossref
Jumi Hayaki, Bradley J. Anderson & Michael D. Stein. (2008) Drug use expectancies among nonabstinent community cocaine users. Drug and Alcohol Dependence 94:1-3, pages 109-115.
Crossref
Sergio Abanades, Magi Farré, Diego Barral, Marta Torrens, Neus Closas, Klaus Langohr, Antoni Pastor & Rafael de la Torre. (2007) Relative Abuse Liability of γ-Hydroxybutyric Acid, Flunitrazepam, and Ethanol in Club Drug Users. Journal of Clinical Psychopharmacology 27:6, pages 625-638.
Crossref
Elizabeth L. van der Kam, Jean De Vry & Thomas M. Tzschentke. (2007) Effect of 2-methyl-6-(phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat. Behavioural Pharmacology 18:8, pages 717-724.
Crossref
Tammy L. Anderson & Philip R. Kavanaugh. (2007) A ‘Rave’ Review: Conceptual Interests and Analytical Shifts in Research on Rave Culture. Sociology Compass 1:2, pages 499-519.
Crossref
. (2007) Abuso de medicamentos: ¿la adicción del siglo XXI?. FMC - Formación Médica Continuada en Atención Primaria 14:5, pages 255-262.
Crossref
R. De La GarzaIIII, K. R. Fabrizio & A. Gupta. (2006) Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology 189:4, pages 425-434.
Crossref
Jeffrey T. Parsons, Brian C. Kelly & Brooke E. Wells. (2006) Differences in club drug use between heterosexual and lesbian/bisexual females. Addictive Behaviors 31:12, pages 2344-2349.
Crossref
Perry N. Halkitis & Joseph J. Palamar. (2006) GHB use among gay and bisexual men. Addictive Behaviors 31:11, pages 2135-2139.
Crossref
Kim Wolff & Adam R Winstock. (2006) Ketamine. CNS Drugs 20:3, pages 199-218.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.